#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia recurrent Anal fistula Hereditary angioedema with C1 esterase inhibitor deficiency Giant cell tumour of tendon sheath Polyneuropathy Mastocytosis Transitional cell cancer of the renal pelvis and ureter Anal cancer recurrent Kaposi's sarcoma Mantle cell lymphoma recurrent Pleomorphic liposarcoma Richter's syndrome Demyelination Sarcoidosis Tuberous sclerosis complex More trials…

    Learn about Rare Diseases

    Antisynthetase syndrome – Treatment Basal cell naevus syndrome – Diagnostics VEXAS syndrome – Diagnostics Erdheim-Chester disease Marginal zone lymphoma – Treatment Haemophilia – Treatment Ewing’s sarcoma recurrent Progressive supranuclear palsy – Life with Disease Factor VIII deficiency – Trials in Disease Mucopolysaccharidosis III – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Naxitamab Risdiplam Vafidemstat Rbl035.2 Aceclofenac Selgantolimod Alemtuzumab Midostaurin SAR444336 Nebivolol Hydrochloride KETOROLAC Ltx-315 Timothy Grass Pollen Extract Masupirdine Emavusertib Ep0042 Plasma Nortriptyline Hydrochloride Nalbuphine Hydrochloride Magnesium Chloride More therapies…

    Learn about Your Condition

    Metabolic disorder Infertility male Strongyloidiasis Muscle strain Marginal zone lymphoma Haemofiltration Procedural anxiety Arthritis infective Chronic myeloid leukaemia Placenta praevia Cervix carcinoma Haemorrhage intracranial Generalised anxiety disorder Androgenetic alopecia Immune-mediated enterocolitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A Study Testing the Safety of IRL757 in Adults with Parkinson’s Disease Who Have Apathy

    Recruiting

    1 1
    Investigated Diseases:
    • Parkinson’s disease
    Bulgaria Germany Poland Spain

  • Study of Heart and Blood Vessel Side Effects in Cancer Patients Receiving Immune Checkpoint Inhibitor Drug Combination Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    • Malignant melanoma
    • Bladder cancer
    Investigated Drugs:
    • Atezolizumab
    • Durvalumab
    • Ipilimumab
    Hungary

  • Study of flumazenil for preventing emergence delirium in children after ear, nose and throat surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Anaesthetic complication neurological
    Investigated Drugs:
    • Sodium Chloride
    Germany

  • A Study Comparing Melatonin versus Placebo for Mood Stabilization in Patients with Bipolar Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Melatonin
    • Placebo
    Denmark

  • Sodium-glucose cotransporter-2 inhibitor drug combination for patients with diabetes and heart attack to slow coronary artery disease progression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetes mellitus
    • Acute myocardial infarction
    Investigated Drugs:
    • Canagliflozin
    • Empagliflozin
    • Dapagliflozin
    Italy

  • Testing Caffeine Citrate for Reducing Breathing Support Needs in Premature Newborns with Primary Apnea

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infantile apnoea
    Investigated Drugs:
    • Caffeine Citrate
    Czechia
Previous Page
1 … 79 80 81 82 83 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!